![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
Teva Pharmaceutical Industries Ltd and Celltrion Healthcare announce that the companies have entered into an exclusive partnership to commercialize two of Celltrion’s mAb biosimilar...
Drug Research
Daiichi Sankyo, AgonOx ink immuno-oncology research collaboration
Daiichi Sankyo Company, Limited has entered into a strategic collaboration with AgonOx, Inc., a privately held biotechnology company, to develop an undisclosed immuno-oncology target....
Drug Research
Recursion Pharmaceuticals Raises $13M To Discover New Drugs Using Artificial Intelligence
Recursion Pharmaceuticals announced its $12.9 million Series A round of funding, led by leading deep technology investor Lux Capital, with participation from Obvious Ventures,...
Drug Research
Bayer and DelSiTech Partner to Develop Innovative Drug Delivery Technology for Ophthalmology
Bayer and DelSiTech Ltd , a Finnish drug delivery technology and drug development company, have signed a Collaboration and Technology Licence Agreement for the...
Drug Research
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Amgen and Arrowhead Pharmaceuticals Inc announced two license and collaboration agreements to develop and commercialize RNA interference (RNAi) therapies for cardiovascular disease. ...
Drug Research
Boehringer Ingelheim boosts immune-oncology pipeline through collaboration with viratherapeutics
Boehringer Ingelheim and ViraTherapeutics announced a long term collaboration to jointly develop a next generation oncolytic virus therapy platform and to investigate Vira Therapeutic’s...
Drug Research
Catalent Showcases Advanced Formulations, Development Technologies And Drug Delivery Solutions At CPhI Worldwide
Catalent Pharma Solutions (Booth 3J16), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products announced...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read